IP Library Granted Patent US 8,260,393
Granted Patent B2
US 8,260,393 · App. 11/762,638 · Granted Sep 4, 2012

Systems and methods for replacing signal data artifacts in a glucose sensor data stream

Assignee: DexCom, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,260,393
App. No.
11/762,638
Filed
Jun 13, 2007
Granted
Sep 4, 2012
Kind
B2
Art Unit
3735
USPC
600/345
Abstract

Systems and methods for detecting noise episodes and processing analyte sensor data responsive thereto. In some embodiments, processing analyte sensor data includes filtering the sensor data to reduce or eliminate the effects of the noise episode on the signal.

Claims (16)

1. A system configured to continuously measure an analyte in a host, the system comprising:

an analyte sensor configured to provide sensor data indicative of an analyte concentration in a host;

electronics operably connected to the sensor, the electronics configured to detect an amplitude and a duration of the sensor data, and further configured to detect a signal artifact event based at least in part on a condition exceeding a threshold, said condition being determined by the amplitude and the duration associated with the sensor data, and configured to output analyte data based on the sensor data, wherein the outputted analyte data is based at least in part upon the signal artifact event detection.

2. The system of claim 1 , wherein detecting a signal artifact event comprises determining an amplitude of the sensor data and determining an amplitude of a signal artifact.

3. The system of claim 1 , wherein detecting a signal artifact event comprises detecting a start and an end of the signal artifact event.

4. The system of claim 1 , wherein the electronics are configured to output the analyte data to an insulin pump via wireless or wired transmission.

5. The system of claim 1 , further comprising an insulin pump device, wherein the electronics are configured to output the analyte data to the insulin pump device, and wherein the insulin pump device is configured to determine an amount of insulin to administer based on the outputted analyte data.

6. The system of claim 5 , wherein the insulin pump device is further configured to determine a time to administer insulin based on the analyte data.

7. A system configured to continuously measure an analyte in a host, the system comprising:

an analyte sensor configured to provide sensor data indicative of an analyte concentration in a host;

electronics operably connected to the sensor and comprising programming configured to detect an amplitude and a duration of the sensor data, and further configured to detect a signal artifact event based at least in part on a condition exceeding a threshold, said condition being determined by the amplitude and the duration of a signal artifact, and programming configured to display on an electronic display a graphical representation of filtered data responsive to a determination of a start of the signal artifact event.

8. The system of claim 7 , wherein the sensor data comprises unfiltered data, and wherein the electronics further comprises programming configured to display a graphical representation of the unfiltered data responsive to a determination of an end of the signal artifact event.

9. The system of claim 7 , wherein the sensor data comprises unfiltered data, and wherein the electronics further comprises programming configured to display a graphical representation of the unfiltered data except when a signal artifact event has been detected.

10. The system of claim 7 , wherein the electronics further comprises programming to output data to an insulin pump device responsive to the signal artifact event detection.

11. The system of claim 10 , further comprising an insulin pump device, wherein the insulin pump device comprises programming configured to determine an amount of insulin to administer based on the analyte data.

12. The system of claim 11 , wherein the insulin pump device comprises programming configured to determine a time to administer insulin based on the analyte data.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2007
From: KAMATH, APURV ULLAS; MAHALINGAM, AARTHI; LI, YING; SHARIATI, MOHAMMAD ALI; BRAUKER, JAMES H.; BRISTER, MARK; BOOCK, ROBERT
To: DEXCOM, INC.
Reel/Frame 019525/0014 →
Continuity (21)
Continuation In Part 11498410 · Aug 2, 2006
Continuation In Part 10648849 · Aug 22, 2003
Continuation In Part 11007920 · Dec 8, 2004
Continuation In Part 11077739 · Mar 10, 2005
Continuation In Part 11762638
Continuation In Part 11750907 · May 18, 2007
Continuation In Part 11675063 · Feb 14, 2007
Continuation In Part 11503367 · Aug 10, 2006
Continuation In Part 11439630 · May 23, 2006
Continuation In Part 11077715 · Mar 10, 2005
Continuation In Part 11404417 · Apr 14, 2006
Continuation In Part 11404417
Continuation In Part 10896639 · Jul 21, 2004
Provisional Application 60528382 · Dec 9, 2003
Provisional Application 60587787 · Jul 13, 2004
Provisional Application 60587800 · Jul 13, 2004
Provisional Application 60614683 · Sep 30, 2004
Provisional Application 60614764 · Sep 30, 2004
Provisional Application 60683923 · May 23, 2005
Provisional Application 60490009 · Jul 25, 2003
Related Publication 20080033254A1 · Feb 7, 2008